Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Respiratory Research

Fig. 2

From: Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats

Fig. 2

Effect of FK866 on pulmonary artery pressure (ΔPAP). PAP increased significantly in the ischemia-reperfusion (IR) group. The increase in PAP was attenuated significantly by treatment with FK866. Data are expressed as mean ± SD (n = 6 per group). ***p < 0.001, compared with the control group; +++ p < 0.001, compared with the IR group

Back to article page